News
Matcha, the green tea packed with antioxidants, is often hailed as containing properties which prevent disease. Scientists in Salford, UK have shed a ray of light on the claim by testing it on cancer stem cells – with, they say, surprising results.
Matcha, the green tea packed with antioxidants, is often hailed as containing properties which prevent disease. Scientists in Salford, UK have shed a ray of light on the claim by testing it on cancer stem cells – with, they say, surprising results.
In research published in the journal Aging, a team from the Biomedical Research Centre at the University of Salford, used metabolic phenotyping on cell lines of breast cancer stem cells and found that Matcha “shifted cancer cells towards a quiescent metabolic state” and stopped their spread at a relatively low concentration (0.2 mg/ml).They also found that the signalling pathways that promote cancer stem cells indicated that Matcha “strongly affected mTOR signals, weakening components of the 40S ribosome. This raised the possibility that Matcha could be used in place of chemical drugs such as rapamycin.Michael Lisanti, professor of translational medicine at the centre, explained: “Matcha green tea is a natural product used as a dietary supplement with great potential for a range of treatments. But, the molecular mechanism underpinning all that remains largely unknown.“By using metabolic phenotyping, we found that the tea is suppressing oxidative mitochondrial metabolism – in other words it is preventing the cells from ‘re-fuelling’ and therefore they become inactive and die.“The effects on human breast cancer cells were very striking; the active ingredients in Matcha having a surgical effect in knocking out certain signalling pathways.“Our results are consistent with the idea that Matcha may have significant therapeutic potential, mediating the metabolic reprogramming of cancer cells.”The team, who specialise in identifying non-toxic methods of killing cancer stem cells, recently found that Earl Grey tea ingredient, Bergamot kills cancer cells and works as an anti-cholesterol agent.Matcha green tea (MGT) inhibits the propagation of cancer stem cells (CSCs) by targeting mitochondrial metabolism, glycolysis and multiple cell signalling pathways is published in Aging and authored by Gloria Bonuccelli, Federica Sotgia and Michael P Lisanti.
19 May 2026
Tagatose, a low-calorie, natural sweetener with EU-approved health claims, is now exempt from added sugar labelling in the US – a move that could see uptake scale significantly.
Read more
14 May 2026
Via its Global Strategy 2026-2028, Fairtrade International is calling on the food industry to embed fairer sourcing practices and invest in long-term supplier relationships.
Read more
12 May 2026
The Dutch nutrition authority has updated the country's food pyramid, rebalancing animal and plant-based consumption to align with government updates to dietary guidelines.
Read more
7 May 2026
Protein, gut health, functional beverages, and mental wellbeing are the key health-powered trends driving innovation and growth, says Innova Market Insights.
Read more
5 May 2026
The European front-of-pack nutrition logo, Nutri-Score, is now better aligned with the processed food classification NOVA, following a 2026 algorithm update.
Read more
4 May 2026
The cheapest products contain 2.6 more additives and 21% more sugar than higher-priced products, according to a US study by Harvard and food scanning app Yuka.
Read more
1 May 2026
Global organisation UNICEF has released a best practice toolkit on children’s rights and digital marketing, calling on policymakers and industry to stop unhealthy ads.
Read more
30 Apr 2026
Sustainability concerns are driving demand for paper packaging – but without careful design and sourcing, paper packaging may offer “little or no benefit”, say experts.
Read more
29 Apr 2026
Unibio is forging ahead with plans to open the “world’s largest” single-cell protein plant in Saudi Arabia. “The Middle East conflict has reinforced how critical local food production is,” says its CEO.
Read more
28 Apr 2026
Rising inflation, commodity disruption and weakening consumer demand are affecting agricultural markets and manufacturers’ cost strategies.
Read more